Forecast & RatingOnly 1 analyst currently covers 20/20 Biolabs (AIDX.US), with a price target of $5.00 and a rating of "Overweight". The sample is very small, so treat this as a reference only. Data as of May 21, 2026; this does not constitute investment advice.
May 21, 2026
Price forecast
$5.001033.02%
Forecast & RatingBuy
1analysts
Strong buy0.00%
Buy100.00%
Hold0.00%
Sell0.00%
Strong sell0.00%
Strong buy
0
Buy
1
Hold
0
Sell
0
Strong sell
0
Target price forecast
Forecast baselineAug 4, 2026
Forecast met0.0%
Stock price$0.44
Average forecast price$5.0
Highest forecast price$5
Lowest forecast price$5
Average forecast price
$5.0
Highest forecast price
$5
Lowest forecast price
$5
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.